staphylococcu
aureu
commens
bacterium
human
also
pathogen
primarili
opportunist
infecti
agent
aureu
caus
variou
suppur
diseas
food
poison
pneumonia
sepsi
chemotherapeut
treatment
gener
appli
aureu
infecti
diseas
howev
emerg
methicillinresist
staphylococcu
aureu
mrsa
repres
seriou
problem
treatment
aureu
infect
sinc
clinic
mrsa
strain
exhibit
high
level
multidrug
resist
treatment
mrsa
infect
seriou
medic
concern
worldwid
glycopeptid
vancomycin
teicoplanin
often
use
treat
mrsa
infect
howev
vancomycinintermedi
resist
aureu
visa
emerg
late
furthermor
vancomycinresist
aureu
vrsa
first
report
michigan
daptomycin
antibacteri
agent
mrsa
use
recent
daptomycinresist
strain
also
report
thu
like
chemotherapi
aureu
infect
becom
difficult
futur
plant
extract
long
known
exert
antibacteri
effect
among
polyphenol
classifi
flavonoid
eg
catechin
flavonol
tannin
nonflavonoid
eg
phenol
acid
neolignan
especi
well
studi
exampl
shown
tannin
tea
leav
persimmon
antibacteri
effect
streptococcu
mutan
aureu
escherichia
coli
polyphenol
thought
less
like
induc
emerg
resist
strain
gener
antibiot
mode
action
polyphenol
demonstr
caus
cytoplasm
membran
destabil
andor
permeabil
side
effect
agent
also
thought
less
sever
tradit
antibiot
licoric
leguminosa
perenni
found
mediterranean
region
south
russia
central
asia
northern
china
america
plant
tradit
use
medicin
agent
due
antibacteri
antivir
antiinflammatori
calm
effect
glycyrrhetin
acid
major
compon
licoric
extract
previou
studi
shown
glycyrrhetin
acid
mani
properti
includ
antiinflammatori
antiallerg
antipept
ulcer
antivir
activ
antiinflammatori
effect
particularli
well
known
appli
clinic
therapi
report
structur
glycyrrhetin
acid
similar
cortison
steroid
hormon
exert
strong
antiinflammatori
effect
japan
prepar
monoammonium
glycyrrhizin
stronger
neominophagen
c
use
treat
chronic
hepat
glycyrrhetin
acid
also
report
antibacteri
effect
bacteri
speci
mechan
underli
activ
remain
unknown
addit
sever
deriv
glycyrrhetin
acid
exhibit
antiinflammatori
activ
antibacteri
activ
elucid
aim
studi
evalu
antibacteri
effect
glycyrrhetin
acid
deriv
clinic
aureu
strain
investig
mechan
underli
antibacteri
effect
aureu
aureu
cultur
tryptic
soy
broth
tsb
shake
rpm
fifti
clinic
aureu
strain
includ
methicillinsensit
aureu
mssa
strain
mrsa
strain
use
studi
tabl
strain
laboratori
collect
aureu
clinic
isol
depart
bacteriolog
hiroshima
univers
graduat
school
biomed
health
scienc
chemic
defin
medium
cdm
supplement
glucos
mm
sole
carbon
sourc
prepar
necessari
glucos
replac
sugar
lactos
trehalos
sucros
glycyrrhetin
acid
gra
deriv
use
studi
shown
fig
agent
obtain
maruzen
pharmaceut
co
ltd
hiroshima
japan
dipotassium
glycyrrhiz
grk
disodium
succinoyl
glycyrrhetin
grsu
solubil
distil
water
glycyrrhetin
acid
gra
solubil
dimethyl
sulfoxid
dmso
stearyl
glycyrrhetin
gr
glycyrrhetinyl
stearat
grsa
solubil
ethanol
stock
solut
prepar
concentr
mgml
dilut
medium
appropri
concentr
indic
experi
mic
determin
use
microdilut
method
previous
describ
briefli
gra
deriv
adjust
mgl
tsb
serial
dilut
prepar
micropl
thermo
fisher
scientif
roskild
denmark
overnight
bacteri
cultur
adjust
cellsml
dilut
tsb
cellsml
ten
microlit
bacteri
cultur
cellswel
appli
well
total
volum
mic
glycyrrhetin
acid
deriv
determin
plate
incub
h
overnight
cultur
aureu
adjust
bacteri
cultur
inocul
ml
tsb
incub
shake
reach
variou
concentr
either
gra
grsu
ad
medium
growth
monitor
investig
cell
viabil
appropri
dilut
tsb
addit
either
gra
grsu
inocul
onto
tryptic
soy
agar
tsa
plate
overnight
incub
coloni
form
unit
cfu
count
three
independ
experi
perform
mean
sd
calcul
data
analyz
statist
signific
differ
compar
untreat
control
timepoint
twoway
anova
follow
dunnett
post
hoc
test
overnight
cultur
aureu
cell
wash
mm
sodium
phosphat
buffer
pb
ph
suspend
pb
bacteri
suspens
dilut
cellsml
pb
dilut
suspens
inocul
pb
contain
variou
concentr
grsu
mic
mgl
gra
mic
mgl
incub
hour
dilut
reaction
mixtur
plate
onto
tsa
plate
incub
overnight
antibacteri
effect
calcul
ratio
number
surviv
cell
surviv
rate
total
number
bacteria
incub
pb
verifi
cell
number
strain
inocul
pb
dilut
bacteri
suspens
prior
inocul
plate
onto
tsa
incub
overnight
three
independ
experi
perform
mean
sd
calcul
data
analyz
signific
differ
compar
untreat
control
use
twoway
anova
follow
dunnett
post
hoc
test
effect
combin
treatment
gentamicin
wako
pure
chemic
industri
ltd
osaka
japan
chloramphenicol
sigmaaldrich
corpor
tokyo
japan
tetracyclin
wako
pure
chemic
industri
ltd
oxacillin
sigmaaldrich
corpor
ofloxacin
daiichi
sankyo
compani
tokyo
japan
either
gra
grsu
investig
overnight
cultur
aureu
adjust
cellsml
bacteri
suspens
appli
well
plate
antibiot
dissolv
tsb
alon
tsb
contain
either
gra
grsu
mic
agent
stock
solut
gl
gentamicin
oxacillin
ofloxacin
prepar
tsb
tsb
contain
either
gra
grsu
stock
solut
gl
chloramphenicol
tetracyclin
prepar
ethanol
final
concentr
gentamicin
chloramphenicol
tetracyclin
oxacillin
ofloxacin
mgl
mgl
mgl
mgl
mgl
respect
solut
serial
dilut
media
h
incub
mic
determin
describ
fraction
inhibitori
concentr
fic
calcul
method
previous
describ
fic
index
defin
synergi
interact
antagon
respect
overnight
cultur
aureu
cell
inocul
ml
fresh
tsb
cultur
shake
reach
grsu
mic
mgl
ad
medium
h
incub
bacteri
cell
collect
centrifug
x
g
min
store
use
addit
bacteri
cell
without
grsu
treatment
prepar
control
total
rna
extract
bacteri
cell
use
fastrna
pro
blue
kit
mp
biomed
cleveland
oh
usa
accord
manufactur
protocol
cdna
synthes
total
rna
use
fairplay
iii
microarray
label
kit
agil
technolog
santa
clara
ca
usa
accord
manufactur
instruct
agil
earray
platform
agil
technolog
use
design
microarray
probe
design
proteincod
gene
aureu
five
probe
per
gene
microarray
analys
test
grsu
treatment
control
cdna
label
monoreact
dye
monoreact
dye
ge
healthcar
uk
respect
fluoresc
label
cdna
purifi
use
fairplay
iii
microarray
label
kit
agil
technolog
cdna
mix
hybrid
onto
array
use
hirpm
gene
express
hybrid
kit
agil
technolog
array
scan
agil
scanner
data
extract
filter
normal
conduct
use
agil
featur
extract
softwar
accord
manufactur
instruct
experi
perform
use
two
biolog
replic
two
technic
replic
condit
express
data
deposit
gene
express
omnibu
http
wwwncbinlmnihgovgeo
access
compar
differ
control
test
sampl
gene
student
ttest
use
cybert
http
cybertmicroarrayicsuciedu
factor
exhibit
greater
chang
increasedecreas
p
defin
alter
grsu
overnight
cultur
aureu
cell
inocul
ml
tsb
aerob
incub
shake
reach
either
mic
grsu
gra
ad
cultur
bacteri
cell
collect
h
incub
rna
extract
cdna
synthesi
perform
describ
quantit
pcr
perform
lightcycl
nano
system
roch
tokyo
japan
use
cdna
templat
dna
primer
use
shown
tabl
result
normal
housekeep
gene
gyrb
three
independ
experi
perform
mean
se
calcul
chemic
defin
medium
cdm
cdm
contain
mic
mic
grak
grsu
gra
use
experi
overnight
cultur
aureu
adjust
cellsml
glucos
trehalos
sucros
fructos
mm
serial
dilut
either
tsb
tsb
contain
gra
kgra
grsu
mic
mic
final
concentr
agent
bacteri
cultur
cell
appli
well
incub
h
minimum
concentr
sugar
show
visibl
bacteri
growth
determin
investig
effect
amino
acid
requir
use
cdm
contain
amino
acid
necessari
aureu
growth
amino
acid
use
experi
concentr
previous
describ
cdm
prepar
use
serial
dilut
cdm
deplet
amino
acid
bacteri
cultur
cell
appli
well
incub
h
minimum
dilut
rate
show
visibl
bacteri
growth
determin
mic
gra
deriv
shown
tabl
mic
evalu
use
aureu
strain
mrsa
strain
mssa
strain
mic
grk
gr
higher
ga
grsu
grsa
mic
grk
gr
strain
mgl
grsa
exhibit
intermedi
level
mic
test
strain
rang
mgl
except
strain
mgl
mic
gra
grsu
rang
mgl
mgl
respect
distribut
mic
mrsa
mssa
strain
shown
tabl
found
differ
suscept
mrsa
mssa
strain
shown
fig
aureu
growth
inhibit
addit
either
gra
grsu
dosedepend
manner
addit
mic
gra
grsu
fulli
inhibit
growth
aureu
expect
growth
alreadi
inhibit
agent
submic
concentr
mic
also
investig
effect
gra
grsu
cell
viabil
time
cours
experi
fig
result
similar
obtain
od
viabl
cell
number
suppress
addit
either
gra
grsu
dosedepend
manner
bacteri
cell
number
decreas
h
addit
mic
gra
grsu
addit
analyz
methicillinsensit
strain
obtain
similar
find
fig
gra
grsu
exhibit
antimicrobi
activ
aureu
strain
activ
growth
investig
whether
activ
observ
nongrow
condit
treat
aureu
cell
either
gra
grsu
mm
pb
shown
fig
viabl
cell
number
strain
treat
mic
mic
gra
grsu
show
signific
differ
compar
control
treatment
next
evalu
synergist
effect
gra
grsu
combin
antibiot
shown
tabl
strain
test
show
synergi
combin
gentamicin
either
gra
grsu
one
strain
show
synergi
combin
tetracyclin
chloramphenicol
grsu
strain
show
synergi
combin
oxacillin
gra
oxacillin
ofloxacin
erythromycin
effect
interact
combin
grsu
chloramphenicol
ofloxacin
erythromycin
effect
combin
gra
furthermor
mic
antibiot
absenc
presenc
gra
grsu
shown
tabl
synergist
effect
gra
grsu
gentamycin
gentamicinresist
mgl
suscept
strain
strain
mic
mgl
found
tabl
presenc
mic
gra
strain
exhibit
decreas
mic
oxacillin
strain
exhibit
chang
presenc
mic
gra
strain
also
exhibit
decreas
mic
oxacillin
presenc
mic
gra
grsu
strain
exhibit
decreas
mic
gentamicin
presenc
mic
gra
grsu
increas
mic
observ
antibiot
test
studi
tabl
perform
microarray
analysi
identifi
gene
alter
express
pattern
respons
grsu
summar
fig
gene
exhibit
alter
express
level
respons
grsu
among
phagerel
gene
increas
addit
grsu
aureu
genom
two
phagerel
operon
found
specif
operon
gene
express
gene
increas
mani
gene
respons
metabol
biosynthet
pathway
also
exhibit
alter
express
pattern
tabl
express
level
gene
involv
protein
synthesi
gene
rna
synthesi
gene
amino
acid
metabol
increas
wherea
level
gene
rna
synthesi
gene
carbohydr
metabol
gene
amino
acid
metabol
decreas
addit
express
level
transport
substratebind
protein
gene
increas
gene
decreas
grsu
treatment
regard
pathogen
factor
express
factor
increas
factor
decreas
found
microarray
analysi
express
level
sever
virulencerel
gene
alter
respons
grsu
analyz
gene
express
rnaiii
key
factor
involv
express
mani
virul
gene
detail
quantit
pcr
shown
fig
rnaiii
express
significantli
increas
exponenti
phase
absenc
gra
grsu
wherea
gra
grsu
fulli
suppress
rnaiii
express
mic
express
seh
rnaiiidepend
virul
factor
exhibit
pattern
similar
rnaiii
respons
gra
grsu
fig
result
suggest
repress
rnaiii
grsu
may
explain
alter
gene
express
sever
virulencerel
gene
observ
microarray
analysi
fig
therefor
investig
express
level
virul
factor
found
sever
toxin
sea
clfab
hlgc
downregul
gra
wherea
cell
surfac
factor
fnba
ica
upregul
fig
effect
grsu
virul
factor
express
similar
gra
amino
acid
carbohydr
metabol
tend
decreas
follow
exposur
gra
grsu
base
microarray
analysi
hypothes
gra
grsu
may
inhibit
growth
aureu
influenc
amino
acid
carbohydr
metabol
therefor
investig
sugar
amino
acid
requir
presenc
gra
grsu
grak
mic
mic
final
concentr
agent
shown
tabl
minimum
concentr
sugar
growth
aureu
cdm
contain
glucos
sucros
lactos
trehalos
increas
presenc
mic
gra
grsu
wherea
grak
increas
sugar
requir
addit
investig
amino
acid
requir
gra
grsu
treatment
caus
higher
requir
compar
untreat
bacteria
mic
gra
grsu
use
minim
concentr
sugar
amino
acid
alter
studi
demonstr
antibacteri
activ
gra
grsu
aureu
strain
two
compound
exhibit
strong
antibacteri
activ
antibacteri
activ
gra
deriv
gr
grk
grsa
much
weaker
gra
grsu
grsu
synthes
gra
ad
succin
acid
moieti
increas
water
solubl
grk
dipotassium
glycyrrhiz
potassium
salt
glycyrrhizin
gra
two
glucuron
acid
also
high
water
solubl
grsu
grk
high
water
solubl
antibacteri
effect
grk
much
lower
grsu
thu
differ
water
solubl
relat
differ
antibacteri
activ
among
compound
instead
structur
differ
two
agent
fig
may
affect
antibacteri
activ
aureu
strain
gra
grsu
clinic
use
antiinflammatori
agent
taken
togeth
find
gra
grsu
expect
exert
two
biolog
activ
clinic
import
antibacteri
antiinflammatori
activ
although
sever
investig
regard
antibacteri
effect
gra
report
first
report
use
grsu
antibacteri
agent
glycyrrhetin
acid
deriv
known
antiinflammatori
drug
stronger
neominophagen
c
wellknown
glycyrrhetin
acid
deriv
drug
contain
mgml
monoammonium
glycyrrhizin
hydrat
dose
use
clinic
treat
chronic
hepat
dose
approxim
higher
concentr
use
studi
therefor
gra
grsu
may
potenti
use
aureu
infecti
diseas
caus
antibacteri
antiinflammatori
effect
long
dr
et
al
previous
report
bacteriostat
activ
gra
bactericid
effect
gra
high
concentr
mgl
aureu
studi
also
observ
bactericid
activ
gra
grsu
mic
dose
grsu
mgl
gra
mgl
shown
microarray
analysi
fig
express
level
mani
phagerel
gene
increas
addit
mic
grsu
specul
bactericid
effect
high
dose
grsu
due
phage
inductionmedi
cell
lysi
among
gene
exhibit
alter
express
follow
addit
grsu
mani
gene
involv
sugar
tabl
amino
acid
tabl
nucleic
acid
tabl
metabol
significantli
decreas
moreov
express
level
mani
gene
encod
transport
also
decreas
tabl
result
suggest
gra
grsutreat
inhibit
uptak
nutrient
caus
alter
express
gene
relat
nutrient
metabol
support
hypothesi
aureu
requir
higher
concentr
sugar
amino
acid
presenc
gra
grsu
absenc
compound
tabl
base
find
propos
gra
grsu
specif
mechan
antibacteri
activ
induc
antimicrobi
effect
inhibit
nutrient
acquisit
affect
bacteri
metabol
addit
express
sever
transport
respons
efflux
andor
influx
compound
increas
microarray
analysi
transport
alter
express
level
presenc
either
gra
grsu
includ
transport
might
involv
high
suscept
gentamicin
presenc
either
gra
grsu
gra
grsu
weak
synergist
activ
protein
synthesi
inhibitor
specul
transport
specif
gentamicin
influx
may
influenc
gra
grsu
studi
found
express
rnaiii
respons
regul
mani
aureu
virul
factor
fulli
repress
gra
grsu
rnaiii
relat
agr
quorum
sens
system
rnaiii
express
growth
depend
found
gra
grsu
suppress
growth
dosedepend
manner
suggest
rnaiii
express
inhibit
investig
express
sever
virul
factor
presenc
absenc
gra
grsu
shown
fig
express
level
toxin
enterotoxin
seh
sea
staphylokinas
sak
hlgc
decreas
wherea
express
level
cell
surfac
factor
fnba
ica
increas
result
hypothes
gra
grsu
modul
virul
addit
antimicrobi
effect
aureu
conclus
found
indic
antibacteri
activ
gra
grsu
mostli
occur
via
effect
nutrient
metabol
addit
agent
suppress
express
sever
virul
gene
taken
togeth
previou
report
inflammatori
effect
gra
grsu
may
potenti
clinic
use
aureu
infecti
diseas
